U.S. Promo Spend Continued To Fall In 2012
Pharmaceutical promotional spend in the U.S. has dropped steeply over the last five years as companies have cut their sales forces, causing the number of office visits to drop and sampling to decline.
You may also be interested in...
The number of pharmaceutical sales reps in the US grew to the highest levels in 2016 since 2011. The trend has continued in 2017, fueled by growth in oncology, where there have been new launches.
Two companies in the biopharma space began trading publicly this week, one to pay off debt, the other to fund an early-stage pipeline.
The biotech is shifting gears after clinical hold on its lead drug was unlikely to be lifted, but the early-stage candidate that it's placing its hopes on is raising red flags for analysts and investors.